The primary endpoint was annualised relapse rate ( number of relapses per patient-year ) and the key secondary endpoint was time to sustained accumulation of disability ( an EDSS score increase of at least 1 EDSS point sustained for a minimum of 12 weeks ) , both analysed in the modified intention-to-treat population ( all patients who received at least one dose of assigned study medication ) .